AR
HY
ZH-CN
EN
DE
EL
IT
FA
PT
ES
TR
JP
When men begin exploring treatment options for benign prostatic hyperplasia (BPH), their primary goal is often clear: find lasting relief from frustrating urinary symptoms. However, for many patients, another important question quickly follows: “Will this treatment affect my sexual function?”
One area of growing focus is ejaculatory function. Some men worry about the psychological impact, while others may be thinking about intimacy, fertility, or maintaining a sense of normalcy after treatment. The reassuring news is that modern BPH therapies increasingly recognize these priorities. Many minimally invasive treatments are specifically designed to relieve symptoms while reducing the risk of sexual side effects.
Understanding how different treatments may influence ejaculatory function is a critical step toward making a confident, informed decision. By knowing what to expect, and what options are available, you can work with your urologist to choose a treatment that supports both your urinary health and overall quality of life.
Ejaculation is a coordinated process involving the prostate, seminal vesicles, bladder neck, and pelvic muscles. During orgasm, semen is propelled through the urethra and exits the body.
A key player in this process is the bladder neck, which closes tightly during ejaculation to prevent semen from flowing backward into the bladder. When this mechanism is disrupted, for instance, sometimes as a result of prostate treatment, ejaculation may change.
One of the most frequently discussed sexual side effects of BPH treatment is retrograde ejaculation, sometimes called a “dry orgasm.”
With retrograde ejaculation:
While retrograde ejaculation is not harmful to overall health, it can be surprising for patients who weren’t expecting it. For some men, particularly those who wish to maintain fertility, it may be an important factor when choosing a treatment approach.
Some procedures relieve urinary symptoms by removing or reshaping prostate tissue near structures involved in semen emission. When these areas are altered, the bladder neck may not close as effectively during orgasm.
It’s important to remember that not all treatments carry the same level of risk. In fact, many newer minimally invasive therapies are specifically designed to reduce the likelihood of ejaculatory dysfunction while still providing meaningful symptom relief.
Advancements in BPH care have led to the development of treatments that not only relieve urinary symptoms, but also prioritize the preservation of sexual function. While no procedure can guarantee zero risk, the following treatments are widely recognized for their ability to effectively treat BPH while offering a lower likelihood of ejaculatory dysfunction compared to traditional surgeries.
The iTind (Temporary Implantable Nitinol Device) is a minimally invasive treatment that works by gently reshaping the prostate to improve urine flow, without cutting, heating, or permanently removing tissue.
A small, flexible device is temporarily placed in the prostate, where it creates channels that reduce obstruction. After several days, the device is removed, leaving the newly widened pathways in place.
Why it may help preserve ejaculation:
Long-term data from the MT02 clinical trial confirms that sexual function is typically preserved following iTind. In fact, studies published by both the European and French Associations of Urology show that patients maintained their baseline sexual health while achieving significant urinary relief.
Rezum Water Vapor Therapy uses the natural energy stored in steam to treat excess prostate tissue. By delivering controlled bursts of water vapor directly into the prostate, the procedure causes targeted cells to break down, allowing the body to gradually absorb them over time.
Why it stands out:
Rezum has been associated with a relatively low rate of ejaculatory dysfunction compared to more invasive surgical procedures. Since the treatment is localized, it helps reduce the likelihood of interfering with the bladder neck and ejaculatory pathways.
The UroLift System takes a mechanical approach to treating BPH. Instead of removing tissue, small implants are used to gently lift and hold enlarged prostate tissue away from the urethra, reducing blockage. A key differentiator is that UroLift was specifically developed to relieve symptoms while preserving sexual function, and clinical data consistently supports its strong track record in this area.
Benefits include:
For many patients, this makes UroLift one of the most reassuring options when sexual health is a top priority.
Choosing to treat BPH is ultimately about taking back comfort, confidence, and control over your daily life. While concerns about sexual side effects, particularly changes in ejaculation, are completely valid, they should never prevent you from seeking the care you need.
If maintaining ejaculatory function is important to you, the most important step is having an open, honest conversation with a qualified urologist. Every patient is different, and the right treatment should align with your medical needs, lifestyle, and personal priorities.
You no longer have to assume that treating BPH means sacrificing an important part of your sexual health. With the right guidance and a personalized approach, it is increasingly possible to achieve lasting symptom relief without compromise. Book an appointment with our world-class urologist today.
